Heterogeneous nuclear ribonucleoproteins C1/C2 identified as autoantigens by biochemical and mass spectrometric methods

Arthritis Research

Volumn 2, Issue 5, 2000, Pages 407-414

  Heegaard, Niels H H ^a   Larsen, Martin R ^b   Muncrief, Terri ^a   Wiik, Allan ^a   Roepstorff, Peter ^b  

^a STATENS SERUM INSTITUT   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Antinuclear antibodies; Autoantibodies; Heterogeneous nuclear; Mass spectrometry; Ribonucleoproteins C1 C2

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIGEN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENOUS NUCLEAR RIBONUCLEOPROTEIN C1; HETEROGENOUS NUCLEAR RIBONUCLEOPROTEIN C2; TRYPSIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIGEN SPECIFICITY; ARTICLE; BIOCHEMISTRY; CELL NUCLEUS; CELL SEPARATION; CONTROLLED STUDY; DATA BASE; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; PEPTIDE MAPPING; POLYMYOSITIS; PROTEIN ANALYSIS; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SCLERODERMA; SERUM; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADULT; AGED; ANTIBODIES, ANTINUCLEAR; AUTOANTIGENS; CELL EXTRACTS; CELLS, CULTURED; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP C; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMANS; MALE; MIDDLE AGED; MOLECULAR WEIGHT; RHEUMATIC DISEASES; RIBONUCLEOPROTEINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 0034468293     PISSN: 14659905     EISSN: None     Source Type: Journal    
DOI: 10.1186/ar119     Document Type: Article

References (21)

1. Autoimmune response to the spliceosome: An immunologic link between rheumatoid arthritis, mixed connective tissue disease, and systemic lupus erythematosus
2. The concurrence of rheumatoid arthritis and limited systemic sclerosis: Clinical and serologic characteristics of an overlap syndrome
3. Autoantibodies to the A/B proteins of the heterogeneous nuclear ribonucleoprotein complex: Novel tools for the diagnosis of rheumatic diseases
4. Heterogenous nuclear RNP C1 and C2 core proteins are targets for an autoantibody found in the serum of a patient with systemic sclerosis and psoriatic arthritis
5. Correlation of acidic and basic carrier ampholyte and immobilized pH gradient two-dimensional gel electrophoresis patterns based on mass spectrometric protein identification
6. Mass spectrometric identification and microcharacterization of proteins from electrophoretic gels: Strategies and applications
7. Error-tolerant identification of peptides in sequence databases by peptides sequence tags
8. Identification of autoantibodies to the I protein of the heterogeneous nuclear ribonucleoprotein complex in patients with systemic sclerosis
9. Molecular definition of heterogeneous nuclear ribonucleoprotein R (hnRNP R) using autoimmune antibody: Immunological relationship with hnRNP P
10. Anti-A2/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribobucleoprotein complex: Differential epitope recognition in rheumatoid arthritis, systemic lupus mixed connective tissue disease
11. Neue ergebnisse zum mechanismus der silberfärbung
12. Immunoblotting - General principles and procedures
13. A sample purification and preparation technique based on nanoscale RP-columns for the sensitive analysis of complex peptide mixtures by MALDI-MS
14. Primary structure differences between proteins C1 and C2 of HeLa 40S nuclear ribonucleoprotein particles
15. Primary structures of the heterogeneous nuclear ribonucleoprotein A2, B1, and C2 proteins: A diversity of RNA binding protein is generated by small peptide inserts
16. Interaction of the RNA-binding domain of the hnRNP C proteins with RNA
17. The heterogeneous nuclear ribonucleoprotein C protein tetramer binds U1, U2, and U6 snRNAs through its high affinity RNA binding domain (the bZIP-like motif)
18. Oligonuceotide binding specificities of the hnRNP C protein tetramer
19. Identification and characterization of the packaging proteins of core 40S hnRNP particles
20. Demonstration of a new antinuclear antibody (anti-RA33) that is highly specific for rheumatoid arthritis
21. The A2 protein of the heterogeneous nuclear ribonucleoprotein